Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2011
Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stabilityVinod Pant, Shunbin Xiong, Tomoo Iwakuma, et al.Analytical Biochemistry|July 5, 2015
An improved intrafemoral injection with minimized leakage as an orthotopic mouse model of osteosarcomaHiromi Sasaki, Swathi V Iyer, Ken Sasaki, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
The combination of EWSR1-FLI1 and loss of one EWSR1 allele leads to the induction of trisomy 8Harsha Hapugaswatta, Alejandro Parrales, Hyewon Park, et al.Plos One|January 24, 2014
Furin is the major proprotein convertase required for KISS1-to-Kisspeptin processingSitaram Harihar, Keke M Pounds, Tomoo Iwakuma, et al.Molecular Cancer Research : MCR|June 24, 2008
Mdm2 and Mdm4 loss regulates distinct p53 activitiesJuan A Barboza, Tomoo Iwakuma, Tamara Terzian, et al.Oncogene|September 14, 2004
Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null miceTomoo Iwakuma, John M Parant, Mark Fasulo, et al.Plos One|June 22, 2017
Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcomaAnup K Kundu, Swathi V Iyer, Sruti Chandra, et al.Clinical & Experimental Metastasis|March 15, 2017
Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancerKen Sasaki, Hiroshi Kurahara, Eric D Young, et al.Oncotarget|December 25, 2015
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activitiesSwathi V Iyer, Alejandro Parrales, Priya Begani, et al.Cancer Research|May 13, 2010
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistanceAmit S Adhikari, Neeraj Agarwal, Byron M Wood, et al.Pageof 7